SimuTech Group Engineers Contribute to Medical Device VVUQ Handbook

SimuTech Group engineers Mark Goodin and Ertan Taskin have co-authored a chapter for an open-access handbook focused on the verification, validation, and uncertainty quantification (VVUQ) of computational modeling for medical devices. The chapter specifically addresses blood pump simulation, offering guidance on how simulations can support design decisions throughout a device's lifecycle, from initial concept to regulatory filings.

### Money Play This development highlights the increasing emphasis on computational modeling and simulation in the medical device industry. Investors in companies involved in medical technology and simulation software may find this an area of growing importance for innovation and regulatory compliance.

## Catalyst Analysis: Medical Device Modeling Handbook SimuTech Group announced the publication of a new chapter co-authored by two of its principal engineers, Mark Goodin and Ertan Taskin, in an open-access handbook on the VVUQ of computational modeling for medical devices. The chapter focuses on blood pump simulation and discusses methods for establishing the credibility of these models, with principles applicable to other blood-contacting devices. The authors will present practical applications from the chapter during a live webinar scheduled for Thursday, September 10, 2026.

The handbook was funded by Ansys, part of Synopsys, and Johnson & Johnson. The collaboration underscores the industry's commitment to advancing the use of simulation in medical device development.

## $SNPS+WL Technical Analysis & Key Risk Watch Key levels for $SNPS+WL (educational): R2 $425.64 · R1 $412.34 · last $412.32 · S1 $411.28 · S2 $400.68.

### Sector Ripple / Impact on Medical Technology While no specific medical device companies are directly cited as catalysts, the content of the handbook, focusing on simulation and validation, could be relevant to broader trends in the medical technology sector. Companies like Johnson & Johnson ($JNJ+WL), mentioned as a funder, and Synopsys ($SNPS+WL), whose subsidiary Ansys funded the publication, are key players in areas related to this development. Advances in simulation credibility can support the design and approval of innovative medical devices.